Parathyroid Hormone (PTH) With Alendronate for Osteoporosis - Contacts and Locations

Home Search Study Topics Glossary

Parathyroid Hormone (PTH) With Alendronate for Osteoporosis

This study has been completed.

Study NCT00005006. Last updated on March 4, 2008.

Information provided by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00005006

Locations

United States, New York
Helen Hayes Hospital, Clinical Research Center
West Haverstraw, New York, United States, 10993

Sponsors and Collaborators

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Investigators

Principal Investigator:	Robert Lindsay, MD	Helen Hayes Hospital
Principal Investigator:	Felicia Cosman, MD	Helen Hayes Hospital